Form 4: Vestis Corp Director Holloman Acquires $215,513 in Common Stock
SEC Form 4 Filing
Director James Phillip Holloman purchased 20,400 shares of Vestis Corp (VSTS) common stock at an average price of $10.5673 on May 8, 2024, increasing his holdings to 64,532.414 shares.
Summary
- On May 8, 2024, James Phillip Holloman, a director of Vestis Corp (VSTS), acquired 20,400 shares of common stock.
- The shares were purchased at a weighted average price of $10.5673 per share.
- The total value of the purchase was approximately $215,513.
- Following the transaction, Holloman directly owns 64,532.414 shares of Vestis Corp.
- The purchase was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It's a common practice for directors and officers to buy or sell shares of their own company, and these transactions are subject to regulatory oversight to prevent insider trading.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of stock purchase transaction |
| 05/10/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.